MOSCOW (MRC) -- At Evonik Catalyst’s manufacturing site in Dombivli, India, the company is commissioning a new plant initially for the production of KALCATTM and in the long-term also Metalyst Activated Metal Catalysts, said the company.
This new state of the art production facility allows Evonik to fully utilize its capacities in Dombivli while establishing significant synergies with the Activated Metal Catalyst production site in Germany.
Activated Metal Catalysts are used in the food industry for the production of sorbitol, the manufacture of active pharmaceutical ingredients (APIs) and in the production of fine and industrial chemicals, for example in the polyurethane value chain. The benefit to customers will be increased supply security of high quality catalysts which are critical raw materials for most industrial processes. The growth rate for India and the rest of Asia in the catalyst market, is forecasted to be significantly higher than in other regions of the world. Therefore, this expansion and upgrade of operations will safeguard the supply of the established product range as well as allowing Evonik to expand the portfolio targeting new markets and applications.
"With this new production facility we will be able to increase our ability to supply our customers with technologically advanced products in India and abroad", states Dr. Thomas Tacke, Managing Director Evonik Catalysts India. Dr. Steffen Hasenzahl, Head of Business Line Catalyst adds: “This expansion of operations in Dombivli is part of our long-term strategy to enhance the expertise and capabilities in the Asia Pacific region. Additionally, it is an important step forward in our commitment to support our valued partners in the region.” “It is one more step towards the company’s commitment to increase our footprint in the growth region” concluded, Mr. Sanjeev Taneja, President and Managing Director, Evonik India.
As MRC informed previously, Evonik Resource Efficiency will invest in a capacity expansion of its performance foams business at its production site in Darmstadt, Germany. The investment will increase the output of the facility by about 20% as a first step. The Group will be adding production equipment to its operations complex that manufactures products marketed under the Rohacell brand. The expanded production capacity is expected to be operational by the second half of 2017.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2018, the enterprise generated sales of EUR15 billion and an operating profit (adjusted EBITDA) of EUR2.6 billion.
MRC